ID   MHPC_ECOLI              Reviewed;         288 AA.
AC   P77044; P71204; P77205; Q2MC75;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   14-DEC-2011, sequence version 4.
DT   15-MAR-2017, entry version 138.
DE   RecName: Full=2-hydroxy-6-oxononadienedioate/2-hydroxy-6-oxononatrienedioate hydrolase;
DE            EC=3.7.1.14 {ECO:0000269|PubMed:15663941};
DE   AltName: Full=2-hydroxy-6-ketonona-2,4-diene-1,9-dioic acid 5,6-hydrolase;
DE   AltName: Full=2-hydroxy-6-oxonona-2,4,7-triene-1,9-dioic acid 5,6-hydrolase;
DE   AltName: Full=2-hydroxy-6-oxonona-2,4-diene-1,9-dioic acid 5,6-hydrolase;
GN   Name=mhpC; OrderedLocusNames=b0349, JW0340;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RA   Kawamukai M.;
RT   "Complete sequence of the mhp operon.";
RL   Submitted (JUN-1996) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND FUNCTION AS A HYDROLASE.
RC   STRAIN=K12 / CS520;
RX   PubMed=9098055; DOI=10.1128/jb.179.8.2573-2581.1997;
RA   Ferrandez A., Garcia J.L., Diaz E.;
RT   "Genetic characterization and expression in heterologous hosts of the
RT   3-(3-hydroxyphenyl)propionate catabolic pathway of Escherichia coli K-
RT   12.";
RL   J. Bacteriol. 179:2573-2581(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RA   Chung E., Allen E., Araujo R., Aparicio A.M., Davis K., Duncan M.,
RA   Federspiel N., Hyman R., Kalman S., Komp C., Kurdi O., Lew H., Lin D.,
RA   Namath A., Oefner P., Roberts D., Schramm S., Davis R.W.;
RT   "Sequence of minutes 4-25 of Escherichia coli.";
RL   Submitted (JAN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [6]
RP   PROTEIN SEQUENCE OF 2-18, FUNCTION AS A HYDROLASE, BIOPHYSICOCHEMICAL
RP   PROPERTIES, AND SUBUNIT.
RX   PubMed=9315862; DOI=10.1021/bi971115r;
RA   Lam W.W., Bugg T.D.;
RT   "Purification, characterization, and stereochemical analysis of a C-C
RT   hydrolase: 2-hydroxy-6-keto-nona-2,4-diene-1,9-dioic acid 5,6-
RT   hydrolase.";
RL   Biochemistry 36:12242-12251(1997).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES,
RP   MUTAGENESIS OF SER-44; SER-114; HIS-118 AND HIS-267, ACTIVE SITE, AND
RP   REACTION MECHANISM.
RX   PubMed=15663941; DOI=10.1016/j.jmb.2004.11.032;
RA   Li C., Montgomery M.G., Mohammed F., Li J.-J., Wood S.P., Bugg T.D.H.;
RT   "Catalytic mechanism of C-C hydrolase MhpC from Escherichia coli:
RT   kinetic analysis of His263 and Ser110 site-directed mutants.";
RL   J. Mol. Biol. 346:241-251(2005).
RN   [8]
RP   MUTAGENESIS OF ASN-113; PHE-177; ARG-192; CYS-265 AND TRP-268, AND
RP   CATALYTIC MECHANISM.
RX   PubMed=17029402; DOI=10.1021/bi061253t;
RA   Li C., Li J.-J., Montgomery M.G., Wood S.P., Bugg T.D.H.;
RT   "Catalytic role for arginine 188 in the C-C hydrolase catalytic
RT   mechanism for Escherichia coli MhpC and Burkholderia xenovorans LB400
RT   BphD.";
RL   Biochemistry 45:12470-12479(2006).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 5-288 IN COMPLEX WITH A
RP   NON-CLEAVABLE SUBSTRATE ANALOG, MASS SPECTROMETRY, AND SUBUNIT.
RX   PubMed=15663942; DOI=10.1016/j.jmb.2004.11.033;
RA   Dunn G., Montgomery M.G., Mohammed F., Coker A., Cooper J.B.,
RA   Robertson T., Garcia J.-L., Bugg T.D.H., Wood S.P.;
RT   "The structure of the C-C bond hydrolase MhpC provides insights into
RT   its catalytic mechanism.";
RL   J. Mol. Biol. 346:253-265(2005).
CC   -!- FUNCTION: Catalyzes the cleavage of the C5-C6 bond of 2-hydroxy-6-
CC       oxononadienedioate and 2-hydroxy-6-oxononatrienedioate, a dienol
CC       ring fission product of the bacterial meta-cleavage pathway for
CC       degradation of phenylpropionic acid. MhpC shows some selectivity
CC       for the carboxylate of the side chain.
CC       {ECO:0000269|PubMed:15663941, ECO:0000269|PubMed:9098055,
CC       ECO:0000269|PubMed:9315862}.
CC   -!- CATALYTIC ACTIVITY: (2Z,4E)-2-hydroxy-6-oxonona-2,4-diene-1,9-
CC       dioate + H(2)O = (2Z)-2-hydroxypenta-2,4-dienoate + succinate.
CC       {ECO:0000269|PubMed:15663941}.
CC   -!- CATALYTIC ACTIVITY: (2Z,4E,7E)-2-hydroxy-6-oxonona-2,4,7-triene-
CC       1,9-dioate + H(2)O = (2Z)-2-hydroxypenta-2,4-dienoate + fumarate.
CC       {ECO:0000269|PubMed:15663941}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2.1 uM for 2-hydroxy-6-oxononadienedioate (at pH 8)
CC         {ECO:0000269|PubMed:9315862};
CC         KM=6.8 uM for 2-hydroxy-6-oxononadienedioate (at pH 8)
CC         {ECO:0000269|PubMed:15663941};
CC         Note=Kcat is 28 sec(-1) for hydrolase activity with 2-hydroxy-6-
CC         oxononadienedioate as substrate. {ECO:0000269|PubMed:15663941};
CC   -!- PATHWAY: Aromatic compound metabolism; 3-phenylpropanoate
CC       degradation.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:15663942,
CC       ECO:0000269|PubMed:9315862}.
CC   -!- MASS SPECTROMETRY: Mass=31717; Method=Electrospray; Range=8-288;
CC       Evidence={ECO:0000269|PubMed:15663942};
CC   -!- MISCELLANEOUS: MhpC is not a serine hydrolase (catalytic triad),
CC       as Ser-114 is a non-nucleophilic catalytic residue and Asp-239 is
CC       not involved in the catalytic mechanism.
CC   -!- SIMILARITY: Belongs to the AB hydrolase superfamily. MhpC family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB18073.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=BAA13054.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=BAE76131.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=CAA70749.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D86239; BAA13054.1; ALT_INIT; Genomic_DNA.
DR   EMBL; Y09555; CAA70749.1; ALT_INIT; Genomic_DNA.
DR   EMBL; U73857; AAB18073.1; ALT_INIT; Genomic_DNA.
DR   EMBL; U00096; AAC73452.3; -; Genomic_DNA.
DR   EMBL; AP009048; BAE76131.1; ALT_INIT; Genomic_DNA.
DR   PIR; E64762; E64762.
DR   RefSeq; NP_414883.5; NC_000913.3.
DR   RefSeq; WP_000121907.1; NZ_LN832404.1.
DR   PDB; 1U2E; X-ray; 2.10 A; A/B/C/D=1-288.
DR   PDBsum; 1U2E; -.
DR   ProteinModelPortal; P77044; -.
DR   SMR; P77044; -.
DR   BioGrid; 4260729; 8.
DR   DIP; DIP-10207N; -.
DR   IntAct; P77044; 3.
DR   STRING; 511145.b0349; -.
DR   ESTHER; ecoli-mhpc; Carbon-carbon_bond_hydrolase.
DR   MEROPS; S33.995; -.
DR   PaxDb; P77044; -.
DR   PRIDE; P77044; -.
DR   EnsemblBacteria; AAC73452; AAC73452; b0349.
DR   EnsemblBacteria; BAE76131; BAE76131; BAE76131.
DR   GeneID; 944954; -.
DR   KEGG; ecj:JW0340; -.
DR   KEGG; eco:b0349; -.
DR   PATRIC; 32115831; VBIEscCol129921_0357.
DR   EchoBASE; EB4168; -.
DR   EcoGene; EG20275; mhpC.
DR   eggNOG; ENOG4106HB6; Bacteria.
DR   eggNOG; COG0596; LUCA.
DR   HOGENOM; HOG000028063; -.
DR   InParanoid; P77044; -.
DR   KO; K05714; -.
DR   BioCyc; EcoCyc:MHPCHYDROL-MONOMER; -.
DR   BioCyc; MetaCyc:MHPCHYDROL-MONOMER; -.
DR   BRENDA; 3.7.1.14; 2026.
DR   UniPathway; UPA00714; -.
DR   EvolutionaryTrace; P77044; -.
DR   PRO; PR:P77044; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005737; C:cytoplasm; IDA:EcoliWiki.
DR   GO; GO:0052823; F:2-hydroxy-6-oxonona-2,4,7-trienedioate hydrolase activity; IDA:EcoCyc.
DR   GO; GO:0018771; F:2-hydroxy-6-oxonona-2,4-dienedioate hydrolase activity; IDA:EcoCyc.
DR   GO; GO:0016787; F:hydrolase activity; IDA:EcoliWiki.
DR   GO; GO:0019622; P:3-(3-hydroxy)phenylpropionate catabolic process; IMP:EcoCyc.
DR   GO; GO:0019380; P:3-phenylpropionate catabolic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0019439; P:aromatic compound catabolic process; IMP:EcoliWiki.
DR   Gene3D; 3.40.50.1820; -; 1.
DR   HAMAP; MF_01654; MhpC; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR000073; AB_hydrolase_1.
DR   InterPro; IPR000639; Epox_hydrolase-like.
DR   InterPro; IPR023791; MhpC_alpha/beta_hydrolase.
DR   Pfam; PF12697; Abhydrolase_6; 1.
DR   PRINTS; PR00111; ABHYDROLASE.
DR   PRINTS; PR00412; EPOXHYDRLASE.
DR   SUPFAM; SSF53474; SSF53474; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Aromatic hydrocarbons catabolism; Complete proteome;
KW   Direct protein sequencing; Hydrolase; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:9315862}.
FT   CHAIN         2    288       2-hydroxy-6-oxononadienedioate/2-hydroxy-
FT                                6-oxononatrienedioate hydrolase.
FT                                /FTId=PRO_0000207054.
FT   ACT_SITE    267    267       Proton acceptor.
FT                                {ECO:0000269|PubMed:15663941}.
FT   SITE        114    114       Transition state stabilizer.
FT                                {ECO:0000269|PubMed:15663941}.
FT   SITE        192    192       Catalytic role in ketonization of the
FT                                dienol substrate (substrate
FT                                destabilization).
FT                                {ECO:0000269|PubMed:15663941,
FT                                ECO:0000269|PubMed:17029402}.
FT   MUTAGEN      44     44       S->A: 2-fold decrease in catalytic
FT                                efficiency and more than 5-fold increase
FT                                in affinity for the natural substrate.
FT                                {ECO:0000269|PubMed:15663941}.
FT   MUTAGEN     113    113       N->A: 200-fold decrease in catalytic
FT                                activity and almost 2-fold increase in
FT                                affinity. {ECO:0000269|PubMed:17029402}.
FT   MUTAGEN     113    113       N->H: 350-fold decrease in catalytic
FT                                activity and almost 2-fold increase in
FT                                affinity. {ECO:0000269|PubMed:17029402}.
FT   MUTAGEN     114    114       S->A: Weakly active. 3-fold decrease in
FT                                affinity. Fast ketonisation and slow C-C
FT                                cleavage. {ECO:0000269|PubMed:15663941}.
FT   MUTAGEN     114    114       S->G: Weakly active. 3-fold decrease in
FT                                affinity. Fast ketonisation and slow C-C
FT                                cleavage. {ECO:0000269|PubMed:15663941}.
FT   MUTAGEN     118    118       H->A: More than 2-fold decrease in
FT                                catalytic efficiency and 3-fold increase
FT                                affinity. {ECO:0000269|PubMed:15663941}.
FT   MUTAGEN     177    177       F->D: 100-fold decrease in catalytic
FT                                activity. {ECO:0000269|PubMed:17029402}.
FT   MUTAGEN     177    177       F->G: 4-fold and 8-fold decrease in
FT                                catalytic activity and affinity,
FT                                respectively.
FT                                {ECO:0000269|PubMed:17029402}.
FT   MUTAGEN     192    192       R->K: 40-fold and 5-fold decrease in
FT                                catalytic activity and affinity,
FT                                respectively.
FT                                {ECO:0000269|PubMed:17029402}.
FT   MUTAGEN     192    192       R->Q: 280-fold and 10-fold decrease in
FT                                catalytic activity and affinity,
FT                                respectively.
FT                                {ECO:0000269|PubMed:17029402}.
FT   MUTAGEN     265    265       C->A: 2-fold decrease in catalytic
FT                                activity and almost 2-fold increase in
FT                                affinity. {ECO:0000269|PubMed:17029402}.
FT   MUTAGEN     267    267       H->A: Weakly active, 1000-fold decrease
FT                                in catalytic efficiency. Very slow
FT                                ketonisation and C-C cleavage.
FT                                {ECO:0000269|PubMed:15663941}.
FT   MUTAGEN     268    268       W->G: 10-fold and 20-fold decrease in
FT                                catalytic activity and affinity,
FT                                respectively.
FT                                {ECO:0000269|PubMed:17029402}.
FT   CONFLICT    153    153       E -> G (in Ref. 1; BAA13054).
FT                                {ECO:0000305}.
FT   HELIX         8     11       {ECO:0000244|PDB:1U2E}.
FT   STRAND       12     19       {ECO:0000244|PDB:1U2E}.
FT   STRAND       22     31       {ECO:0000244|PDB:1U2E}.
FT   STRAND       35     41       {ECO:0000244|PDB:1U2E}.
FT   HELIX        50     53       {ECO:0000244|PDB:1U2E}.
FT   TURN         54     57       {ECO:0000244|PDB:1U2E}.
FT   HELIX        58     63       {ECO:0000244|PDB:1U2E}.
FT   STRAND       67     71       {ECO:0000244|PDB:1U2E}.
FT   HELIX        88    102       {ECO:0000244|PDB:1U2E}.
FT   STRAND      108    113       {ECO:0000244|PDB:1U2E}.
FT   HELIX       115    126       {ECO:0000244|PDB:1U2E}.
FT   HELIX       128    130       {ECO:0000244|PDB:1U2E}.
FT   STRAND      131    138       {ECO:0000244|PDB:1U2E}.
FT   STRAND      146    148       {ECO:0000244|PDB:1U2E}.
FT   HELIX       153    163       {ECO:0000244|PDB:1U2E}.
FT   HELIX       167    175       {ECO:0000244|PDB:1U2E}.
FT   HELIX       186    198       {ECO:0000244|PDB:1U2E}.
FT   HELIX       200    212       {ECO:0000244|PDB:1U2E}.
FT   HELIX       221    226       {ECO:0000244|PDB:1U2E}.
FT   STRAND      231    236       {ECO:0000244|PDB:1U2E}.
FT   STRAND      240    242       {ECO:0000244|PDB:1U2E}.
FT   HELIX       245    253       {ECO:0000244|PDB:1U2E}.
FT   STRAND      258    264       {ECO:0000244|PDB:1U2E}.
FT   HELIX       269    272       {ECO:0000244|PDB:1U2E}.
FT   HELIX       274    285       {ECO:0000244|PDB:1U2E}.
SQ   SEQUENCE   288 AA;  31937 MW;  8F7E5ADE584A45BA CRC64;
     MSYQPQTEAA TSRFLNVEEA GKTLRIHFND CGQGDETVVL LHGSGPGATG WANFSRNIDP
     LVEAGYRVIL LDCPGWGKSD SVVNSGSRSD LNARILKSVV DQLDIAKIHL LGNSMGGHSS
     VAFTLKWPER VGKLVLMGGG TGGMSLFTPM PTEGIKRLNQ LYRQPTIENL KLMMDIFVFD
     TSDLTDALFE ARLNNMLSRR DHLENFVKSL EANPKQFPDF GPRLAEIKAQ TLIVWGRNDR
     FVPMDAGLRL LSGIAGSELH IFRDCGHWAQ WEHADAFNQL VLNFLARP
//
